Evaluation of a Preoperative Education in Total Knee Arthroplasty
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Cabazitaxel in Platinum Refractory Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Cabazitaxel for Recurrent Malignant Glioma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating System Accuracy of Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)
- Status
- COMPLETED
- Phase
- PHASE1
Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Status
- COMPLETED
- Phase
- PHASE2
China STEMI-PCI Program
- Status
- UNKNOWN
- Phase
- N/A
Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators
- Status
- COMPLETED
- Phase
- N/A
To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
- Status
- COMPLETED
- Phase
- PHASE2